McKesson management check
MCK · Health Care · Health Care Distributors · CEO Brian S. Tyler
Filings as of
5 good · 1 to watch · 1 flagged, across the seven questions below.
- Good
Have owners done well?
Beat its chosen peers$100 invested at the start of fiscal 2022 grew to $456, against $137 for the peer group the company picked itself.
- Flag
Does pay follow performance?
Pay moved against returnsOver 5 years, the CEO's pay actually paid (equity valued at the share price) had a correlation of -0.33 with shareholder return. 1 means pay moved in step; below 0, the opposite way.
- Good
What does the CEO cost owners?
0.5% of net income$24.2m of reported pay in fiscal 2026, against $4.8bn of net income.
- Watch
Do they own the stock?
CEO stake ≈ 0.2 years of payThe CEO holds 5,919 shares, directly or through trusts (unvested awards not counted): about 0.2 years of pay. Light activity: no buys, $24.8m sold in six months. 11 of 12 sales ran on pre-arranged 10b5-1 plans.
- Good
Are owners being diluted?
Share count shrinkingDiluted shares changed -3.8% a year over the last three fiscal years. Stock-based pay was 0.1% of revenue in the latest year.
- Good
Is leadership stable?
5 leadership filings in 3 yearsCEO in the pay table: Brian S. Tyler. 5 filings under 8-K item 5.02 (officers or directors leaving or joining, or new pay arrangements) in the last 3 years.
- Good
Are the books clean?
No red flags on fileNo restatements, auditor changes or late filings since 2021.
Against the S&P 500
Each check's score (0–100) and how it compares: the share of ranked S&P 500 companies it matches or beats, and the median in Health Care.
| Check | Score | At or above | Sector median |
|---|---|---|---|
| Owner returns | 100 | 26 | |
| Pay for performance | 34 | 85 | |
| CEO cost | 74 | 44 | |
| Skin in the game | 0 | 46 | |
| Dilution | 98 | 68 | |
| Stable leadership | 100 | 70 | |
| Clean books | 100 | 100 |
Closest peers
Others in Health Care Distributors, by management score. McKesson is 15th of 60 in its sector.
- 45CAHCardinal Health81
- 149SYKStryker Corporation72
- 150MCKMcKesson72
- 156ISRGIntuitive Surgical72
- 233CORCencora66
- 419HSICHenry Schein50
Pay versus performance
From the proxy statement filed June 12, 2026. "Actually paid" values stock awards at the share price, so it rises and falls with the stock.
| Fiscal year | CEO | CEO pay | Actually paid | Other executives (avg) | $100 became | Peers | Net income |
|---|---|---|---|---|---|---|---|
| 2026 | Brian S. Tyler | $24.2m | $48.9m | $5.5m | $456 | $137 | $4.8bn |
| 2025 | — | $20.2m | $39.2m | $5.0m | $353 | $134 | $3.3bn |
| 2024 | — | $19.0m | $51.7m | $5.2m | $281 | $133 | $3.0bn |
| 2023 | — | $20.2m | $38.8m | $4.9m | $185 | $115 | $3.6bn |
| 2022 | — | $18.2m | $65.3m | $4.5m | $158 | $119 | $1.1bn |
The board says pay is tied most to Adjusted EPS. Its other key measures: Adjusted Operating Profit, Free Cash Flow, Average ROIC.
Insiders and the CEO's stake
Brian S. Tyler (Chief Executive Officer) held 5,919 shares directly after their latest Form 4 on Jul 7, 2026, roughly $4.7m at that filing's price.
Light activity: no buys, $24.8m sold in six months. 11 of 12 sales ran on pre-arranged 10b5-1 plans.
- SoldBrian S. TylerChief Executive Officer · 10b5-1 plan$17.0mJul 7, 2026
- SoldMichele LauEVP and Chief Legal Officer · 10b5-1 plan$2.7mMay 26, 2026
- SoldThomas L RodgersEVP, Chief Strategy & BDO · 10b5-1 plan$2.4mJun 2, 2026
- SoldLeAnn B SmithEVP & Chief HR Officer · 10b5-1 plan$1.3mJun 1, 2026
Leadership and governance on file
- Jul 1, 2026Leadership change8-K 5.02
- Mar 5, 2026Leadership change8-K 5.02
- Jun 3, 2024Leadership change8-K 5.02
- Jan 9, 2024Leadership change8-K 5.02
- Nov 1, 2023Leadership change8-K 5.02
- Oct 3, 2023Leadership change8-K 5.02
- Sep 13, 2022Leadership change8-K 5.02
- Apr 29, 2022Leadership change8-K 5.02
- Apr 1, 2022Leadership change8-K 5.02
- Feb 22, 2022Leadership change8-K 5.02
- Jan 18, 2022Leadership change8-K 5.02
Latest shareholder vote results: Jul 24, 2026, including the say-on-pay vote.
Where the money went
Over 2021–2025: $19.7bn returned to owners in buybacks and dividends, 125% of net income, and $978.0m of pay in stock.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $264.0bn | $276.7bn | $309.0bn | $359.1bn | $403.4bn |
| Net income | $1.1bn | $3.6bn | $3.0bn | $3.3bn | $4.8bn |
| Stock-based pay | $161.0m | $162.0m | $182.0m | $226.0m | $247.0m |
| Buybacks | $3.5bn | $3.6bn | $3.0bn | $3.1bn | $4.8bn |
| Dividends | $277.0m | $292.0m | $314.0m | $345.0m | $381.0m |
| Diluted shares | 154m | 142m | 134m | 128m | 124m |
Educational only, not investment advice. Figures are as filed with the SEC: pay from the proxy's pay-versus-performance table, capital allocation from 10-K XBRL data, insider trades from Form 4s over the last six months, events from the last 5 years of filings. The peer group is the one the company chose. See the method.